ABSTRACT
Numerous physiologic and pathologic situations are enhanced by undesirable muscle activity. This is often noticed in facial aging deformity where it is reflected in the presence of frown lines, crow's feet, and platysmal bands as well as in cases of blepharospasm, spastic type cerebral palsy, trismus, and torticolis. Botulinum toxin A (BtxA) is a presynaptic blocker of Acetyl-choline release and therefore causes muscle relaxation. 1 Since its introduction it has gained popularity in the treatment of various muscle contraction related medical conditions. 2, 3 BtxA injection for treatment of facial wrinkles is thought to be the most popular aesthetic treatment worldwide. It is estimated that 4.5 million people are treated annually in the United States with a revenue of 1.7 billion USD. 4 BtxA treatment, though effective and simple, requires repeated injections every 3 to 4 months and is therefore costly as well as time and effort consuming. Patients and surgeons often try to find more permanent solutions to overcome these drawbacks. Myotomy of the involved muscle is often a long-term alternative to treat conditions affected by muscle hyperactivity. Examples of such procedures are Corrugator and Procerus myotomies during a forehead lift, 5 Platysma myotomy as part of a neck lift or as a solitary procedure, 6 Sterno-cleido-mastoidotomy for torticolis, 7, 8 or mastication muscles myotomy for trismus. 9 These procedures have variable success rates due to muscle healing and partial or even complete regeneration of muscle activity. Within 5 to 6 days from myotomy, the necrotized part of the severed myofibers inside the remaining old basal lamina is replaced by regenerating contractilemyofibers, which then begin to penetrate the forming connective tissue scar that occupies the gap between the stumps of the ruptured muscle, enhancing scar retraction. The retraction of the scar pulls the severed muscle edges closer to each other, leaving them separated only by a thin layer of connective tissue to which they remain attached by newly formed myotendinous junctions. 10, 11 Since it has been found that the distal segment of an injured muscle initially isolated from its nerve supply shows histologic changes suggestive of denervation (fiber atrophy and size variability, increased fibrosis, and nuclear centralization) we hypothesized that blocking muscle activity with BtxA during the healing time of striated muscle after myotomy will alter the healing process and prevent or significantly delay long-term muscle activity.
METHODS
The study was conducted during June to November 2016. To test our hypothesis, we used a Latisimus Dorsi myotomy rat model. All animal procedures were performed at the Ben Gurion University animal research facility after approval of the animal ethics committee. Eighteen adult (mean age: 6 months, range: 4-7 months) Sprague Dawley rats weighing 250 to 500g were randomly divided into 3 groups: group A (n = 7) underwent myotomy of their right Latisimus Dorsi muscle; group B (n = 7) underwent myotomy of their right Latisimus Dorsi muscle and injection of BtxA (Botox, Allergan plc, Dublin, Ireland) (9 units/ kg) into the severed muscle; group C (n = 4) underwent injection of BtxA (9 units/kg) into their right Latisimus Dorsi muscle without severing the muscle. Since the direct effect of BtxA on muscle activity has been extensively studied and well established in the literature, group C was included in the study to serve as a biological assay to the direct effect of BtxA. Animal randomization was achieved by blind pulling a folded paper from a box with assignment to a certain group for each animal before taking the first measurements of weight and preprocedure (T0) grip test.
Surgical Procedure
Animals were anesthetized using Isoflurane 2% to 3%. Their dorsal skin hair was shaved with a clipper and the skin was disinfected with 5% Chlorhexidine. A 4 cm skin incision was performed over the right cephalic dorsal torso. Tissue was dissected and the right Latisimus Dorsi muscle was exposed (Figure 1 ). In groups A and B, the muscle was cut perpendicular to muscle fibers along its whole width approximately 1 cm lateral from its origin at the spinal column. In group B, after myotomy BtxA (9 units/kg) was injected into both sides of the injured muscle. In group C, no myotomy was performed and only BtxA (9 units/kg) was injected into the muscle in the same region as in group B. The skin incisions were closed with surgical staples in all groups. After surgery the animals were kept in separate cages and received Dipyrone up to 200 mg/kg in their drinking water as postoperative analgesia. Food and water were administrated ad libitum. The animals were inspected daily by a veterinarian doctor for the first three days, and once a week thereafter. The animals were weighed at three time points: at the beginning of the study, in the middle (week 11), and at the end of the study (week 22).
Muscle Strength Test
Muscle strength was tested using a grip test, which is a commonly used method to test rodent limb muscle strength. 12, 13 In this test the animal is held by its tail as it holds onto a metal grid with its front limbs. Then the animal is pulled away until it loses its grip. The grid is connected to a scale that records the maximal grip strength in grams as the animal is pulled away from the grid. Using a Columbus Instruments (Columbus, OH) grip strength meter, five repetitions were measured for each animal at each time point. Measurements were taken prior to intervention (T0), four weeks following the intervention, and once a week from week 8 to week 22.
Histology
All animals were sacrificed at the end of week 22 and their surgical site was biopsied for histological examination. After embedding the tissue in paraffin and staining with Haematoxylin-Eosin stain, they were examined by a blinded pathologist for difference in qualitative histological features.
Statistical Analysis
At every time point animal grip strength was tested five times and the average result was recorded. Differences between the groups were tested using a-parametric MannWhitney test and a P-value of < 0.05 was considered as statistically significant. Additionally, we normalized each measurement of each animal to its preprocedure result and tested the normalized scores in the same manner. Differences between animal weights were also compared with the Mann-Whitney test. Correlation between animal weight and grip test strength was tested using Pearson's correlation coefficient.
RESULTS
One animal from group B expired at week 21. All other animals tolerated the procedure well and reached the study endpoint. There were no statistically significant differences between the groups' weight or grip strength before intervention. Figure 2 summarizes the results of all three groups during the study period. It is noticeable that the three groups had an insignificant difference of grip test strength prior to intervention, with group B slightly stronger than the two control groups. Immediately after intervention all groups showed a significant reduction in strength at week 4 and then gradually gained strength, even exceeding their preprocedure scores. They reached a peak strength at week 17 followed by a slight reduction thereafter. This elevation-peak-reduction pattern was characteristic for all study groups. However, starting at week 16, group C (BtxA) exceeded both myotomy groups, and group A (Myotomy) exceeded the strength of group B (Myotomy + BtxA) throughout the rest of the study, with increasing difference between the groups at every week from week 16 up to week 22 (P < 0.05). Although not significantly different the initial grip test of group B was slightly higher than that of groups A and C (Figure 2) . Thus, when normalizing the results to preprocedure strength, the difference between groups is accentuated. Biopsies obtained from the surgical site revealed a slight increase in fat infiltrate between muscle fibers in group B vs groups A or C ( Figure 3) ; however, this characteristic was not quantifiable for comparison.
DISCUSSION
It is common in clinical situations such as muscular torticollis, trismus, Platysma bands, and frown lines that the result of surgery is suboptimal due to significant activity regained by the healing muscle. 5, 8 There have been numerous attempts to overcome this problem, mainly through interposition of different barriers between the muscle stumps. These included the use of fat grafts, fascia, or acellular dermal matrix. 7 Most of these interposition techniques were only partially successful. It therefore seemed appealing to investigate whether we could alter the muscle healing process and improve the long-term result of surgical myotomy by a pharmacological, transient, and safe method of using BtxA.
This study was designed to test the hypothesis that transitionally blocking muscle activity at the critical period of muscle repair after injury alters the repair process and will eventually lead to reduced muscle function after the repair process is completed.
We indeed found that BtxA altered the muscle strength of the severed muscle for a prolonged time, beyond its direct effect as a muscle relaxant. It is noticeable that there was a peak in muscle strength measured at 17 weeks Figure 2 . Effect of BtxA on the recovery of muscle after myotomy. *Weeks 12, 13, and 16 to 22, P < 0.05 for surgery vs surgery + BtxA. post-surgery. A possible explanation for this observation is that the grip test measured the total strength pull by the two front limbs. It may be that while the right limb, upon which the experiment was performed, was weakened, the left leg became stronger as a compensation. Once the right leg healed the strength was at its peak and then slightly weakened again. Even if we do not have a sufficient explanation to the peak phenomenon, it was consistent in all three groups, and the difference between the groups remained significant throughout the late stages of the study. Another concern regarding the result is that at the end point the total strength exceeded the initial strength. However, naturally over the long study period the animals grew in size and strength. Again, this finding was true for all three study groups. The mechanism in which BtxA alters muscle repair is yet to be elucidated. It might be attributed to its effect on muscle fibers themselves or through its effect on Satellite cells and their differentiation to Myoblasts and Myotubes. 10, 11 Nevertheless, the results suggest clinical relevance even without profound understanding of the mechanism as BtxA is safely used and approved for those same clinical situations where myotomy is indicated.
Study Limitations
Measurement of grip strength tested the combined strength of both front limbs without separating the treated leg from the healthy one. The follow-up period length, though sufficient enough to prove the concept of BtxA effect on muscle healing, might have demonstrated a much longer, and possibly permanent effect, if measured after a longer follow up.
Study Strengths
A well-controlled study that proved the concept of the long-term physiologic effect of BtxA on the healing process of striated muscle with direct clinical implications.
CONCLUSIONS
This animal study suggests that BtxA administration into severed muscle at the end of a surgical myotomy procedure may contribute to the preservation of the desired decrease in muscle activity achieved by surgery and improve longterm outcome. Clinical trials to verify this concept are needed. 
